Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 192,600 shares, an increase of 31.9% from the January 15th total of 146,000 shares. Currently, 6.2% of the shares of the stock […]
Aptose Biosciences (NASDAQ:APTO – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Analyst Ratings This is a summary of […]
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 146,000 shares, a growth of 66.5% from the December 31st total of 87,700 shares. Based on an average daily trading volume, of 57,100 shares, the […]
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 87,700 shares, an increase of 32.3% from the December 15th total of 66,300 shares. Based on an average daily trading volume, of […]
StockNews.com upgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a sell rating to a hold rating in a research note issued to investors on Monday. APTO has been the topic of several other reports. HC Wainwright increased their target price on Aptose Biosciences from $12.00 to $23.00 and gave the stock a […]